Clinical Trial Update: A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE) [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/Phase 3 trial of PRAX-562 for SCN2A- and SCN8A-related encephalopathies; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scn2a-related Encephalopathy
• Scn8a-related Encephalopathy

Drugs mentioned

• PRAX-562

Snippet

Sponsor: Praxis Precision Medicines | Conditions: SCN2A Encephalopathy, SCN8A Encephalopathy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING